Prediction of progression to a high risk situation in women with gestational hypertension or mild pre-eclampsia at term

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 51, Issue 4, 2011, Pages 339-346

  Van Der Tuuk, Karin ^a   Koopmans, Corine M ^a   Groen, Henk ^a   Aarnoudse, Jan G ^a   Van Den Berg, Paul P ^a   Van Beek, Johannes J ^b   Copraij, Frans J A ^c   Kleiverda, Gunilla ^d   Porath, Martina ^e   Rijnders, Robbert J P ^f   Van Der Salm, Paulien C M ^g   Santema, Job G ^h   Stigter, Robert H ⁱ   Mol, Ben W J ^j   Van Pampus, Maria G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VIECURI MEDICAL CENTER   (Netherlands)

^c VieCuri Medical Centre Noord Limburg ^*  (Netherlands)

^d Flevo Hospital   (Netherlands)

^e MÁXIMA MEDICAL CENTER   (Netherlands)

^f JEROEN BOSCH HOSPITAL   (Netherlands)

^g MEANDER MEDICAL CENTER   (Netherlands)

^h MEDICAL CENTER LEEUWARDEN   (Netherlands)

ⁱ DEVENTER HOSPITAL   (Netherlands)

^j ACADEMIC MEDICAL CENTER   (Netherlands)

more..

Author keywords

gestational hypertension; obstetrics; pre eclampsia; prediction model; randomised controlled trial

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; URIC ACID;

ABORTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CALIBRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ETHNICITY; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PREGNANCY; HUMAN; INTERNAL VALIDITY; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; NULLIPARA; PREDICTIVE VALUE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; URIC ACID BLOOD LEVEL;

ADULT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LABOR, INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 80051886940     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2011.01311.x     Document Type: Article

References (17)

1. Sibai BM, Caritis S, Hauth J,. National Institute of Child Health and Human Development Maternal-Foetal Medicin Units Network. What we have learned about preeclampsia. Semin Perinatol 2003; 27: 239-246.
2. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes maternal death: a systematic review. Lancet 2006; 367: 1066-1074.
3. Schutte JM, Schuitemaker NW, van Roosmalen J, Steegers EA,. Dutch Maternal Mortality Committee. Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands. BJOG 2008; 115 (6): 732-736. (Pubitemid 351514589)
4. Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009; 374: 979-988.
5. Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP,. Risk of uterine rupture during labour among women with a prior cesarean delivery. N Engl J Med 2001; 345 (1): 3-8. (Pubitemid 32640179)
6. Brown MA, Buddle ML,. Hypertension in pregnancy: maternal and foetal outcome according to laboratory and clinical features. Med J Aust 1996; 165: 360-365. (Pubitemid 26354152)
7. Martin JN, May WL, Magann EF, et al. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999; 180: 1407-1414. (Pubitemid 29293259)
8. von Dadelszen P, Magee LA, Davarakonda RM, et al. The prediction of adverse maternal outcomes in preeclampsia. J Obstet Gynaecol Can 2004; 26 (10): 871-879.
9. Thangaratinam S, Ismail K, Sharp S, et al. TIPPS (Tests in Prediction of Preeclamsia's Severity) Review Group. Prioratisation of tests for the prediction of preeclampsia complications: a Delphi survey. Hypertens Pregnancy 2007; 26: 131-138.
10. Van der Heijden GJ, Donders AR, Stijnen T, Moons KG,. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol 2006; 59 (10): 1102-1109. (Pubitemid 44374315)
11. Steyerberg EW, Eijkemans MJ, Habbema JD,. Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 1999; 52 (10): 935-942. (Pubitemid 29486559)
12. Altman DG, Royston P,. What do we mean by validating a prognostic model? Stat Med 2000; 19: 453-473. (Pubitemid 30126878)
13. Verhoeven CJ, Oudenaarden A, Hermus MA, et al. Validation of models that predict Cesarean section after induction of labor. Ultrasound Obstet Gynecol 2009; 34 (3): 316-321.
14. Thangaratinam S, Ismail K, Sharp S, et al. Accuracy of serum uric acidin predicting complications of pre-eclampsia: a systematic review. BJOG 2006; 113: 369-378.
15. Koopmans CM, van Pampus MG, Groen H, et al. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. Eur J Obstet Gynecol Reprod Biol 2009; 146: 8-14.
16. Rinehart BK, Terrone DA, May WL, et al. Change in platelet count predicts eventual maternal outcome with syndrome of hemolysis, elevated liver enzymes and low platelet count. J Matern Fetal Med 2001; 10: 28-34.
17. Coppus SF, van der Veen F, Opmeer BC, et al. Evaluating prediction models in reproductive medicine. Hum Reprod 2009; 24 (8): 1774-1778.